Bioinformatyka i Data Science: LinkedIn / Ardigen
Sztuki walki: Tōgō Dōjō, Chi Ryu
Results from our first PICI-sponsored clinical trial: Phase 1 study combining anti-CD-40, anti-PD-1 & chemo shrank tumors in metastatic #pancreaticcancer patients. Pancreatic cancer is one of the most difficult-to-treat cancers and we're finding answers. https://t.co/Gr39QRCh0B
Delighted to inform you all that Ardigen was accepted into the prestigious Tumor neoantigEn SeLection Alliance working to improve the personalization of #immunotherapies by #neoantigen prediction. https://t.co/1KrgRMuKXV
@ParkerICI #Bioinformatics #Cancer #ArtificialIntelligence
🔬New findings about the interferon pathway having potential to be a biomarker & therapeutic target in #immunotherapy. Research from PICI's Andy Minn @PennCancer in collaboration w/ several other PICI scientists from @pennmedbench + @sloan_kettering. https://t.co/KBeQQxIrcj
We're back to dogma. Remember the paper last year that said the womb wasn't sterile. Well, it appears that was wrong.
https://t.co/7AuqJWPgKG @Nature @sangerinstitute @Cambridge_Uni
https://t.co/QZOXvS6brE @NatureNV @nsegata
New paper on origins of tumor-fighting immune cells after anti-PD-1 #immunotherapy by @HowardYChang @satpathology @StanfordMed + PICI’s Danny Wells, Samantha Bucktrout and Robin Kageyama in @NatureMedicine. A true collaborative effort! https://t.co/SAP2Lwi2j1 https://t.co/CREesNhOio
Very interesting treatment strategy - Dengue virus and DCs - https://t.co/8kkIddSEL6 #immunology #oncology #io #cancervaccine #immunotherapy
Very impressive gut #microbiome science to drive the right foods for promoting its maturation and help remedy malnutrition, as shown in a randomized trial of children
https://t.co/00MfztZdq1
@sciencemagazine
There's been recent use of #AI (particularly ML) to refine our understanding of #diet and nutrition.
A study this week on "hyperfoods" probed which foods have the most #cancer prevention potential @SciReport by @imperialcollege https://t.co/oShfA7qkPG #openaccess
The mathematics of #cancer metastasis
https://t.co/aCbGzVBeVr @PNASNews Insights about seeding (10-150 cells), the stochastic story, and heterogeneity from modeling, by Alex Heyde @jgreiter @naxerova @DrMANowak @Harvard
PICI investigator Phil Greenberg and his colleagues at @fredhutch have engineered T-cells to keep acute myeloid #leukemia from returning in 12 high-risk patients! Trial results were published in @NatureMedicine. #solvecancer #AMLsm 👊 🙌 https://t.co/H0uAqpTcVi